Et tu, J&J?

RSS

I always think of Johnson & Johnson as one of the good guys, so it was very disheartening to read this article in the New York Times (free reg. req'd): Lucrative Drug, Danger Signals and the F.D.A. about its heartburn drug, Propulsid. A snip:

Propulsid's history has striking parallels with the painkillers now at the

center of controversy. Dozens of studies sponsored by Johnson & Johnson that

might have warned doctors away were never published, just as the pharmaceutical

manufacturer Pfizer

failed to publish an early study of Celebrex that indicated a heart risk. And

Johnson & Johnson was able to delay and soften some proposed label changes,

just as Merck

later did with Vioxx.

Please or Register to post comments.

Blog Archive